Marketed by: Lilly USA, LLC Indianapolis, IN 46285, USA MOUNJARO is a registered trademark of Eli Lilly and Company
When used consistently, it can also improve longer-term markers like A1C, which is the average level of blood sugar over two to three months
Top Benefits: Enhances weight loss beyond GLP-1 alone Improves insulin response and glucose stability Boosts overall metabolic performance Once-weekly injectable therapy that mimics the natural GLP-1 hormone to improve appetite control and metabolic efficiency
Perez-Gonzalez, A., Bevant, K
The timing of nausea follows a predictable pattern
Free Weight-Loss Consultation (Pharmacist-Led) Not sure whether Wegovy or Mounjaro is right for you or how to lose weight safely and sustainably